Parmax Pharma Ltd - 540359 - Submission Of Revised Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2019 As Per Regulation 33 Of SEBI (Listing Obligation And Disclosure Requirement) Regulation 2015.
With reference to the above cited subject, we would like to inform your good office that 'Parmax Pharma Ltd' the Company has submitted its Unaudited Financial Results for the quarter and nine months ended 31st December, 2019 through the BSE Portal on Wednesday i.e. 12th February, 2020 and the same was duly informed to stock exchange for dissemination as Corporate Announcement. However, while reviewing the financials again the Company realized that, due to inadvertent typographical error, the amount of Earning per Share (EPS) was not in order. The Company wishes to submit that, there is no malafide intention involved on the part of Company's management and the revised figures have NIL impact on the Profits for the period under review. We are thereby re-submitting the said Financials for Quarter & nine months ended 31st December, 2019 with the corrected quarterly EPS.13-02-2020